(A) Subcutaneous and intramuscular route
(B) Intravenous route
(C) Subcutaneous route
(D) Intradermal and subcutaneous route
May 29, 2022
sinxoo
(A) Inactive metabolite from an active drug
(B) Active metabolite from an active drug
(C) Active metabolite from an inactive drug
(D) Inactive metabolite from inactive drug
May 29, 2022
(A) Stomach
(B) Small intestine
(C) Oesophagus
(D) Large intestine
May 29, 2022
(A) Efficacy
(B) Potency
(C) Affinity
(D) Bioavailability
(B) Potency
(C) Affinity
(D) Bioavailability
May 29, 2022
(A) 100% bioavailable
(B) Rapidly absorbed
(C) Undergoes the first-pass metabolism
(D) Rapidly excreted by renal
May 29, 2022
(A) Affinity to receptors only
(B) Affinity and maximal intrinsic activity
(C) Affinity but no intrinsic activity
(D) Affinity and submaximal intrinsic activity
(B) Affinity and maximal intrinsic activity
(C) Affinity but no intrinsic activity
(D) Affinity and submaximal intrinsic activity
May 29, 2022
(A) Non-parallel left shift
(B) Non-parallel right shift
(C) Parallel right shift
(D) Parallel left shift
(B) Non-parallel right shift
(C) Parallel right shift
(D) Parallel left shift
May 29, 2022
(A) Can cause a parallel shift to the right in a drug-response curve for agonist
(B) Can be reversed by increasing dose of agonist
(C) Appear to decrease the potency of the agonist
(D) All of the above
May 29, 2022
(A) Antagonism.
(B) Noncompetitive
(C) Competitive
(D) Non-competitive and competitive
May 29, 2022
(A) It determines the quantitative relations between dose or concentration of drug and pharmacologic effects.
(B) Responsible for the selectivity of drug action.
(C) Mediates the actions of pharmacological agonists and antagonists.
(D) None of the above
May 29, 2022